AI-generated summary
The authors randomized participants to sinus floor augmentation with Cerabone alone or Cerabone plus photobiomodulation, with biopsies taken at 30 days for histological and immunohistochemical analysis. They report greater bone formation and more advanced bone maturation in the photobiomodulation group, along with higher osteocalcin staining, but no significant difference in TRAP staining. The study included only eight participants.
- Participants
- 8
- Who or what was studied
- Eight participants undergoing maxillary sinus floor augmentation with bovine hydroxyapatite (Cerabone) and randomized to Cerabone alone or Cerabone with photobiomodulation.
- Limits stated in the abstract
- The abstract reports a very small sample of eight participants and a short 30-day evaluation period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The use of non-autogenous biomaterial to increase bone height in the maxillary sinus has been shown to be effective, but the results are still inconclusive.
Material And Methods
Eight participants were selected and included in the research. After surgical access with osteotomy on the lateral wall of both maxillary sinuses, these were filled with Cerabone®. Then, by blind randomization, they received one of the following treatments: Filling with Cerabone® (Control group); treatment with Photobiomodulation (PBM), filling with Cerabone® and treatment with low-power laser (PBM group). Biopsies were obtained 30 days after the surgery, using a 2.8 mm internal diameter trephine bur. Qualitative and quantitative histological analyzes were performed and immunohistochemical analyzes of osteocalcin (OCN) and tartrate-resistant acid phosphatase (TRAP) were performed with scores for each of the biological events.
Results
The Cerabone® biomaterial demonstrated a high degree of biocompatibility. New bone formation was observed in both groups. In the PBM group, there was greater bone formation and newly formed tissue in an advanced state of bone maturation. The immunostaining of OCN was greater at 30 days in the PBM group than in the control. There was no significant difference in TRAP immunostaining at 30 days between the groups.
Conclusions
Low-power laser-mediated by PBM promoted greater bone formation; the newly formed tissue showed a more advanced state of bone maturation in maxillary sinuses filled with Cerabone® biomaterial and treatment with PBM, within the 30-day evaluation period. Key words:Sinus floor augmentation, dental implants, bone and bones, low-level light therapy.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.